-
24 Oct 2026
[Articles] 14-day versus 28-day trifluridine–tipiracil plus bevacizumab for refractory metastatic colorectal cancer (PRABITAS): a pragmatic, multicentre, open-label, randomised, phase 3, non-inferiority trial in Japan
The Lancet
- Views 108
- More stats
-
15 Nov 2026
What the Robot Still Can’t Do
The New England Journal of Medicine
- Views 107
- More stats
-
26 Oct 2026
[Articles] Sacituzumab tirumotecan versus treatment of physician's choice in previously treated endometrial cancer (TroFuse-005/ENGOT-en23/GOG-3095): a randomised, open-label, phase 3 trial
The Lancet
- Views 106
- More stats
-
29 Oct 2026
[Comment] Beyond poverty eradication: what China's health and poverty alleviation experience means for global health
The Lancet
- Views 106
- More stats
-
10 Nov 2026
ANGPTL4 Inhibition in Adults with Elevated Triglyceride Levels
The New England Journal of Medicine
- Views 106
- More stats
-
11 Nov 2026
Engineered bacteria are weaning farms away from synthetic fertilizers
Nature
- Views 106
- More stats
-
29 Oct 2026
Gene Therapy for Phenylketonuria in Adults
The New England Journal of Medicine
- Views 103
- More stats
-
24 Oct 2026
Anbenitamab plus HB1801 for HER2-Positive Advanced Breast Cancer
The New England Journal of Medicine
- Views 102
- More stats
-
04 Nov 2026
Spider snooze stages
Nature
- Views 102
- More stats
-
21 Oct 2026
Programmable design of functional proteins from natural language
Nature
- Views 101
- More stats
Journal Content
Life Science Network features journal content imported from some of the most popular scientific journals. In addition, the Publications module allows you to import or add your own publications to our database. Note that the indicated journal impact factors are not regularly updated.
Check the Publications module here
Advertisement